News

What’s new atT-Cypher Bio

Press releases, the conferences where you can meet our team, and the presentations we have given there.

Press releases

Company news

Announcements and updates from T-Cypher Bio.

Upcoming events

Where to meet usEvents

The conferences and events where our team will be speaking, presenting or available to meet.

Publications

Science we’ve shared

Slides and posters from the conferences where our team has presented. Every presentation is free to download as a PDF.

20262 presentations

  • Poster

    Discovery and preclinical development of a half-life-extended TCR-based bispecific T cell engager targeting a novel cancer antigen presented across multiple solid tumor indications

    SITC 2026 Annual Meeting

    Targeting TC25 with a high affinity bi-specific TCR-TCE drives potent, specific tumor cell killing of TC25-positive solid tumors.

    Dominic Hine et al.

  • Poster

    Pre-clinical development of a best-in-class bispecific T cell engager targeting a highly abundant peptide for the treatment of melanoma

    SITC 2026 Annual Meeting

    TC11 is a highly abundant, broadly expressed HLA bound melanoma target that is presented across diverse melanoma patient cohorts, including tumors previously exposed to checkpoint inhibitor therapy, and enables potent killing by T-Synapse-TC11, a TCR-TCE.

    Samantha Drennan et al.